Article (Scientific journals)
Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysis.
Korenblik, Remon; van Zon, Jasper F J A; Olij, Bram et al.
2022In BJS Open, 6 (6), p. 141
Peer Reviewed verified by ORBi
 

Files


Full Text
zrac141-2.pdf
Publisher postprint (240.98 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Humans; Portal Vein/surgery; Hepatic Veins; Retrospective Studies; Liver Neoplasms/surgery; Hypertrophy
Abstract :
[en] BACKGROUND: Many patients with bi-lobar liver tumours are not eligible for liver resection due to an insufficient future liver remnant (FLR). To reduce the risk of posthepatectomy liver failure and the primary cause of death, regenerative procedures intent to increase the FLR before surgery. The aim of this systematic review is to provide an overview of the available literature and outcomes on the effectiveness of simultaneous portal and hepatic vein embolization (PVE/HVE) versus portal vein embolization (PVE) alone. METHODS: A systematic literature search was conducted in PubMed, Web of Science, and Embase up to September 2022. The primary outcome was resectability and the secondary outcome was the FLR volume increase. RESULTS: Eight studies comparing PVE/HVE with PVE and six retrospective PVE/HVE case series were included. Pooled resectability within the comparative studies was 75 per cent in the PVE group (n = 252) versus 87 per cent in the PVE/HVE group (n = 166, OR 1.92 (95% c.i., 1.13-3.25)) favouring PVE/HVE (P = 0.015). After PVE, FLR hypertrophy between 12 per cent and 48 per cent (after a median of 21-30 days) was observed, whereas growth between 36 per cent and 67 per cent was reported after PVE/HVE (after a median of 17-31 days). In the comparative studies, 90-day primary cause of death was similar between groups (2.5 per cent after PVE versus 2.2 per cent after PVE/HVE), but a higher 90-day primary cause of death was reported in single-arm PVE/HVE cohort studies (6.9 per cent, 12 of 175 patients). CONCLUSION: Based on moderate/weak evidence, PVE/HVE seems to increase resectability of bi-lobar liver tumours with a comparable safety profile. Additionally, PVE/HVE resulted in faster and more pronounced hypertrophy compared with PVE alone.
Disciplines :
Surgery
Gastroenterology & hepatology
Radiology, nuclear medicine & imaging
Author, co-author :
Korenblik, Remon ;  Department of Surgery, Maastricht University Medical Center, Maastricht, The  ; GROW-Department of Surgery, School for Oncology and Reproduction, Maastricht
van Zon, Jasper F J A;  Department of Surgery, Maastricht University Medical Center, Maastricht, The
Olij, Bram;  Department of Surgery, Maastricht University Medical Center, Maastricht, The  ; GROW-Department of Surgery, School for Oncology and Reproduction, Maastricht  ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH
Heil, Jan;  Department of General, Visceral and Transplant Surgery, University Hospital
Dewulf, Maxime J L;  Department of Surgery, Maastricht University Medical Center, Maastricht, The
Neumann, Ulf P;  Department of Surgery, Maastricht University Medical Center, Maastricht, The  ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH
Olde Damink, Steven W M;  Department of Surgery, Maastricht University Medical Center, Maastricht, The  ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH  ; NUTRIM-Department of Surgery, School of Nutrition and Translational Research in
Binkert, Christoph A;  Department of Radiology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
Schadde, Erik ;  Department of General, Visceral and Transplant Surgery, Klinik Hirslanden,  ; Department of General, Visceral and Transplant Surgery, Hirslanden Klink St. Anna
van der Leij, Christiaan;  Department of Radiology, Maastricht University Medical Center+, Maastricht, The
van Dam, Ronald M;  Department of Surgery, Maastricht University Medical Center, Maastricht, The  ; GROW-Department of Surgery, School for Oncology and Reproduction, Maastricht  ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH
DRAGON Trials, Collaborative
Other collaborator :
Aldrighetti, L A
van Baardewijk, L J
Barbier, L
Binkert, C A
Billingsley, K
Björnsson, B
Andorrà, E Cugat
Arslan, B
Baclija, I
Bemelmans, M H A
Bent, C
de Boer, M T
Bokkers, R P H
de Boo, D W
Breen, D
Breitenstein, S
Bruners, P
Cappelli, A
Carling, U
Robert, M Casellas I
Chan, B
De Cobelli, F
Choi, J
Crawford, M
Croagh, D
van Dam, R M
Deprez, F
Detry, Olivier  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie abdo, sénologique, endocrine et de transplantation
Dewulf, M J L
Díaz-Nieto, R
Dili, A
Erdmann, J I
Font, J Codina
Davis, R
Delle, M
Fernando, R
Fisher, O
Fouraschen, S M G
Fretland, Å A
Fundora, Y
Gelabert, A
GERARD, Laurent ;  Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
Gobardhan, P
Gómez, F
Guiliante, F
Grünberger, T
Grochola, L F
Grünhagen, D J
Guitart, J
Hagendoorn, J
Heil, J
Heise, D
Herrero, E
Hess, G
Hilal, M Abu
Hoffmann, M
Iezzi, R
Imani, F
Inmutto, N
James, S
Borobia, F J Garcia
Jovine, E
Kalil, J
Kingham, P
Kollmar, O
Kleeff, J
van der Leij, C
Lopez-Ben, S
Macdonald, A
Meijerink, M
Korenblik, R
Lapisatepun, W
Leclercq, W K G
Lindsay, R
Lucidi, V
Madoff, D C
Martel, G
Mehrzad, H
Menon, K
Metrakos, P
Modi, S
Moelker, A
Montanari, N
Moragues, J Sampere
Navinés-López, J
Neumann, U P
Nguyen, J
Peddu, P
Primrose, J N
Olde Damink, S W M
Qu, X
Raptis, D A
Ratti, F
Ryan, S
Ridouani, F
Rinkes, I H M Borel
Rogan, C
Ronellenfitsch, U
Serenari, M
Salik, A
Sallemi, C
Sandström, P
Martin, E Santos
Sarría, L
Schadde, E
Serrablo, A
Settmacher, U
Smits, J
Smits, M L J
Snitzbauer, A
Soonawalla, Z
Sparrelid, E
Spuentrup, E
Stavrou, G A
Sutcliffe, R
Tancredi, I
Tasse, J C
Teichgräber, U
Udupa, V
Valenti, D A
Vass, D
Vogl, T J
Wang, X
White, S
De Wispelaere, J F
Wohlgemuth, W A
Yu, D
Zijlstra, Ij A J
More authors (118 more) Less
Language :
English
Title :
Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysis.
Publication date :
02 November 2022
Journal title :
BJS Open
ISSN :
2474-9842
Publisher :
Wiley, Us
Volume :
6
Issue :
6
Pages :
zrac141
Peer reviewed :
Peer Reviewed verified by ORBi
Funding number :
Abbott Laboratories/; Maastricht University/
Commentary :
© The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd.
Available on ORBi :
since 29 August 2023

Statistics


Number of views
20 (2 by ULiège)
Number of downloads
11 (1 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
0
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi